Onderneming BetterLife Pharma Inc. Other OTC
Aandelen
BETRF
CA08772P2026
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26-12-10 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05-02-15 |
David Melles
IRC | Investor Relations Contact | - | 29-09-21 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05-02-15 |
Ralph Pullen
BRD | Director/Board Member | 79 | 05-05-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 117 079 397 | 85 332 281 ( 72,88 %) | 0 | 72,88 % |
Bedrijfsgegevens
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+
http://www.abetterlifepharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,85% | 125 mld. | |
+14,24% | 108 mld. | |
-7,08% | 23,64 mld. | |
+2,85% | 22,39 mld. | |
-12,11% | 17,78 mld. | |
-41,74% | 16,43 mld. | |
-15,64% | 16,34 mld. | |
+0,45% | 13,56 mld. | |
+24,49% | 11,59 mld. |